Stay updated with breaking news from Antigen Presenting Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COPENHAGEN, Denmark, May 16, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the discovery and development
COPENHAGEN, Denmark, May 16, 2023 -- Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the discovery and development of AI-powered immunotherapies, today announced that... | May 16, 2023
Q1 Presentation May 12, 2023 Forward-looking statement ... | May 12, 2023
VB10.16 Final Phase 2 data readout - 12 month treatment follow up April 19 2023 ... | April 19, 2023
Published Comprehensive Preclinical Research on SQZ® AAC Platform in Frontiers in ImmunologyContinued Investigational New Drug-Enabling Activities for SQZ® TAC Platform; Submission Expected in First Half of 2023 with Clinical Batches Intended to be Manufactured on the Company’s Point-of-Care SystemAnticipate Interim...